1. Immunization with DNA coding for gp100 results in CD4+ T-cell independent antitumor immunity
2. Schaed SG, Klimek VM, Panageas KS et al, T-cell responses against tyrosinase 368–376(370D) peptide in HLA(⋆)A0201(+) melanoma patients: randomized trial comparing incomplete Freund’s adjuvant, granulocyte–macrophage colony-stimulating factor, and QS-21 as immunological adjuvants. Clin Cancer Res (2002) 8: 967–72.
3. Weiss WR, Ishii KJ, Hedstrom RC et al, A plasmid encoding murine granulocyte–macrophage colony-stimulating factor increases protection conferred by a malaria DNA vaccine. J Immunol (1998) 161: 2325–32.